Anti-CD20 Monoclonal Antibody(Rituximab)
CD20,Bp35,C-type lectin domain family 13 member E,Endocytic receptor 180,Macrophage mannose receptor 2,MS4A1,B1,FMC7,Urokinase-type plasminogen activator receptor-associated protein,UPAR-associated protein,Urokinase receptor-associated protein,B-lymphocyte antigen CD20,Leukocyte surface antigen Leu-16
货号： S0B0570
- 价格： ￥1,550
- 规格：
- 数量：
大包装询价 产品介绍 评论(0)
宿主来源
Human抗原名称
CD20分子别名
B-lymphocyte antigen CD20, Bp35, Leukocyte surface antigen Leu-16, MS4A1Accession
P11836克隆号
S-SC005抗体类型
Recombinant mAb抗体同种型
IgG1应用
Blocking of CD20 signaling Functional assays纯化方式
Protein A浓度
2 mg/ml内毒素含量
<2EU/mg标记
Unconjugated性状
Liquid缓冲体系
PBS pH7.4, containing no preservative储存条件
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.
评论(0)